Skip to content

Sympathetic Activity and Renal Denervation

Influences of Catheter-based Renal Denervation on Central Sympathetic Nervous System Regulation in Refractory Hypertension

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01355055
Acronym
ReD
Enrollment
26
Registered
2011-05-17
Start date
2011-03-31
Completion date
Unknown
Last updated
2011-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

Primary hypothesis: Catheter-based renal denervation reduces central sympathetic activation in patients with refractory hypertension. Secondary hypotheses: 1. The magnitude of the individual depressor response after catheter-based renal denervation depends on the extent of sympathoinhibition. 2. Both, the reduction in arterial pressure and in central sympathetic activation are sustained over time up to 24±3 months after catheter-based renal denervation. 3. Catheter-based renal denervation resets the sympathetic baroreflex to lower blood pressure values.

Interventions

None listed

Sponsors

Hannover Medical School
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Refractory hypertension (as defined by the WHO: poorly controlled hypertension (\>140/90 mmHg) despite adequate doses of at least three antihypertensive drugs including a diuretic) * Men or women aged \>18 years * Intact peroneal nerve * Written informed consent

Exclusion criteria

* Diseases, dysfunctions, or medications (such as NET inhibitors) that exclude a participation in the study according to the investigator. * Legal incompetence or circumstances that interfere with the patient´s ability to fully understand scope, relevance, and/or consequences of participation in this study. * People in custody * hypersensitivity to clonidine, phenylephrine, or nitroprusside-sodium * sick sinus syndrome, second or third degree AV block, bradycardia \< 50 bpm (contraindication for clonidine) * endogenous depression (contraindication for clonidine)

Countries

Germany

Contacts

Primary ContactHeusser Karsten, MD
heusser.karsten@mh-hannover.de+495115322723
Backup ContactReuter Julia, MD
reuter.julia@mh-hannover.de+495115322827

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026